Company / EPS (Diluted)
MEDIFAST INC EPS (Diluted) History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$9.10
FY2025
5-year range
$2.29 / $13.89
FY2021-FY2025
Trend
-28.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 10 years, ranging from $1.03 in FY2016 to $13.89 in FY2023.
Based on SEC 10-K filings.
9.10 in FY2025 with a 10-year CAGR of +18.1%.
Declined from $13.89 to $9.10 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +14.5%
- 10-Year CAGR
- +18.1%
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 28.5% year-over-year.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.08 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.10 | -28.5% |
| FY2024 | $12.73 | -8.4% |
| FY2023 | $13.89 | +200.6% |
| FY2020 | $4.62 | +101.7% |
| FY2019 | $2.29 | +53.7% |
| FY2018 | $1.49 | -10.2% |
| FY2017 | $1.66 | +61.2% |
| FY2016 | $1.03 | -40.5% |
| FY2015 | $1.73 | +49.1% |
| FY2014 | $1.16 | -11.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026